Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

Authors :: William D. Tap
Andrew J. Wagner
A. Lopez Pousa
J. McGill
Silvia Stacchiotti
C-C. Lin
Antoine Yver
Hans Gelderblom
James H. Lewis
Dale Shuster
Sebastian Bauer
John H. Healey
Mihaela Druta
Laurie D. DeLeve
Hideo A. Baba
M. A. J. van de Sande
X. Gu
Source :: Annals of Oncology. 30:v695-v696
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
business.industry
Locally advanced
Pexidartinib
Cancer research
Medicine
Hematology
business
Tenosynovial giant cell tumour

Tools